本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amylyx Pharmaceuticals

15.26
+0.89006.19%
成交量:106.26万
成交额:1,578.87万
市值:16.76亿
市盈率:-8.60
高:15.32
开:14.54
低:14.16
收:14.37
52周最高:17.49
52周最低:2.60
股本:1.10亿
流通股本:6,544.94万
量比:1.28
换手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-1.7742
每股收益(LYR):-4.4281
净资产收益率:-56.52%
总资产收益率:-39.44%
市净率:5.05
市盈率(LYR):-3.45

数据加载中...

2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/27

重要事件披露

Form 8-K - Current report
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]